31 – 40 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
(
- Contribution to journal › Letter
-
Mark
Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
- 2017
-
Mark
Second-look resection for primary stage T1 bladder cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.
2016) In World Journal of Urology(
- Contribution to journal › Article
-
Mark
Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
(
- Contribution to journal › Article
-
Mark
Gender-related differences in urothelial carcinoma of the bladder : a population-based study from the Swedish National Registry of Urinary Bladder Cancer
(
- Contribution to journal › Article
-
Mark
Author Reply
(
- Contribution to journal › Debate/Note/Editorial